Skip to main content
. 2024 May 24;10(2):e004302. doi: 10.1136/rmdopen-2024-004302

Figure 2.

Figure 2

Treatments detected in the spondyloarthritis population. bDMARD, biologic disease-modifying antirheumatic drugs; csDMARD, conventional synthetic disease-modifying antirheumatic drugs; NSAIDs, non-steroidal anti-inflammatory drugs.